Sasaki T et al., demonstrated that knockdown of AKT1, AKT2, or AKT3 by siRNA can suppress the proliferation of PC-3 and DU-145 prostate cancer cells [14], suggesting that all AKT isoforms are involved in the regulation of prostate cancer cells. Here, AKT2 is linked to prostate carcinoma.